£830K
The funding round was led by Chris Torrance and backed by the Angel CoFund alongside a crowd of angel investors.
SP
Small Pharma
Small Pharma develops rapid-acting antidepressant treatments for severe depression.
London, UK—Founded 2015
£830KTotal raised
Small Pharma is a London-based pharmaceutical company focused on developing low-cost treatments for mental health conditions. Its current pipeline includes a rapid-acting antidepressant derived from ketamine.
Categories
Founders
Peter Rands
Managing Director
Peter previously founded Small Pharma, leading the company as chief executive officer until its acquisition by Helus Pharma. His background includes legal and patent roles at Mintz Levin and Teva Pharmaceuticals.
LinkedIn